Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 11, keine Gesamtzahl für „which“
Suchtreffer
Begriffe & Kennungen
Evoltra · 4.8 · The information provided is based on data generated from clinical trials in which 115 patients (> 1 and ≤ 21 y
Eintrag öffnenExelon · 4.5 · Additive effects leading to bradycardia (which may result in syncope) have been reported with the combined use
Eintrag öffnenExelon · 4.5 · Additive effects leading to bradycardia (which may result in syncope) have been reported with the combined use
Eintrag öffnenExelon · 4.5 · Additive effects leading to bradycardia (which may result in syncope) have been reported with the combined use
Eintrag öffnenFareston · 4.5 · Drugs which decrease renal calcium excretion, e.g. thiazide diuretics, may increase the risk of hypercalcaemia
Eintrag öffnenFarydak · 4.5 · In patients who take concomitant medicinal products which are strong CYP3A and/or Pgp inhibitors, including, b
Eintrag öffnenFaslodex · 4.8 · 5 a Includes adverse drug reactions for which the exact contribution of Faslodex cannot be assessed due to the
Eintrag öffnenFilgrastim Hexal · 4.8 · The most commonly reported adverse reactions are pyrexia, musculoskeletal pain (which includes bone pain, back
Eintrag öffnenFirdapse (previously Zenas) · 4.5 · Substances which are potent inducers of enzymes that metabolise medicinal products (see section 5.2) The resul
Eintrag öffnenFirdapse (previously Zenas) · 4.5 · Substances which are potent inhibitors of enzymes that metabolise medicinal products (see section 5.2) Potent
Eintrag öffnenFoclivia · 4.8 · Vascular disorders Vasculitis which may be associated with transient renal involvement.
Eintrag öffnenFoclivia · 4.8 · Vascular disorders Vasculitis which may be associated with transient renal involvement.
Eintrag öffnenFosavance · 4.3 · - Abnormalities of the oesophagus and other factors which delay oesophageal emptying such as stricture or acha
Eintrag öffnenFoscan · 4.8 · The low number of treated patients did not allow identification of adverse reactions, which may be categorised
Eintrag öffnenFycompa · 4.5 · 9 (2-fold), which are known inducers of enzymes of metabolism (see section 5.2). This effect should be taken i
Eintrag öffnenFycompa · 4.8 · In the table below, adverse reactions, which were identified based on review of the full Fycompa clinical stud
Eintrag öffnenFycompa · 4.8 · In the table below, adverse reactions, which were identified based on review of the full Fycompa clinical stud
Eintrag öffnenGalafold · 4.5 · Co-administration of migalastat with caffeine decreases migalastat systemic exposure (AUC and Cmax) which may
Eintrag öffnenGalafold · 4.8 · The most common adverse reaction was headache, which was experienced by approximately 10% of patients who rece
Eintrag öffnenGardasil 9 · 4.8 · In one of these clinical studies which enrolled 1 053 healthy adolescents aged 11 to 15 years, administration
Eintrag öffnen